Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2001 Jun;70(6):739–743. doi: 10.1136/jnnp.70.6.739

Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology

R McShane 1, Z Nagy 1, M Esiri 1, E King 1, C Joachim 1, N Sullivan 1, A Smith 1
PMCID: PMC1737382  PMID: 11385006

Abstract

OBJECTIVES—To assess olfactory function of patients with dementia. Odour detection ability is impaired in clinical Parkinson's disease. Evidence of impaired detection in patients with clinically diagnosed Alzheimer's disease is inconsistent. No studies of olfaction have been neuropathologically validated.
METHODS—The olfactory function of 92 patients with dementia and 94 controls was assessed using a simple bedside test as part of the Oxford Project To Investigate Memory and Ageing (OPTIMA). Neuropathological assessment was made of cortical Lewy bodies and substantia nigra (SN) cell counts and of Alzheimer's disease in all 92 patients, 22 of whom had SN Lewy bodies and 43 of whom had only Alzheimer's disease.
RESULTS—Patients with Lewy bodies were more likely to be anosmic than those with Alzheimer's disease or controls. Patients with Alzheimer's disease were not more likely to be anosmic than controls. Nor was anosmia associated with degree of neurofibrillary tangles, as assessed by Braak stage. Among subjects with Lewy bodies, overall cortical Lewy body scores and Lewy body density in the cingulate were higher in those who were anosmic. Consensus clinical criteria for dementia with Lewy bodies had a sensitivity of 64% and specificity of 89%. In the absence of definite Alzheimer's disease, the criteria had sensitivity of 100%. In patients with definite Alzheimer's disease, anosmia was slightly more sensitive (55%) than the consensus criteria (33%). However, the addition of anosmia to the consensus criteria did not improve their overall performance.
CONCLUSION—Dementia with Lewy bodies is associated with impaired odour detection. Misdiagnosis may have accounted for some previous reports of impaired odour detection in Alzheimer's disease. Simple but more sensitive tests of anosmia are required if they are to be clinically useful in identifying patients with dementia with Lewy bodies.



Full Text

The Full Text of this article is available as a PDF (158.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blessed G., Tomlinson B. E., Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968 Jul;114(512):797–811. doi: 10.1192/bjp.114.512.797. [DOI] [PubMed] [Google Scholar]
  2. Doty R. L., McKeown D. A., Lee W. W., Shaman P. A study of the test-retest reliability of ten olfactory tests. Chem Senses. 1995 Dec;20(6):645–656. doi: 10.1093/chemse/20.6.645. [DOI] [PubMed] [Google Scholar]
  3. Doty R. L., Reyes P. F., Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull. 1987 May;18(5):597–600. doi: 10.1016/0361-9230(87)90129-8. [DOI] [PubMed] [Google Scholar]
  4. Doty R. L., Riklan M., Deems D. A., Reynolds C., Stellar S. The olfactory and cognitive deficits of Parkinson's disease: evidence for independence. Ann Neurol. 1989 Feb;25(2):166–171. doi: 10.1002/ana.410250210. [DOI] [PubMed] [Google Scholar]
  5. Doty R. L., Shaman P., Kimmelman C. P., Dann M. S. University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope. 1984 Feb;94(2 Pt 1):176–178. doi: 10.1288/00005537-198402000-00004. [DOI] [PubMed] [Google Scholar]
  6. Esiri M. M., Wilcock G. K. The olfactory bulbs in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1984 Jan;47(1):56–60. doi: 10.1136/jnnp.47.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  8. Gibb W. R., Mann D. M., Mountjoy C. Q., Lees A. J. A pathological study of the association between Lewy body disease and Alzheimer's disease. Adv Neurol. 1990;53:55–59. [PubMed] [Google Scholar]
  9. Graves A. B., Bowen J. D., Rajaram L., McCormick W. C., McCurry S. M., Schellenberg G. D., Larson E. B. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology. 1999 Oct 22;53(7):1480–1487. doi: 10.1212/wnl.53.7.1480. [DOI] [PubMed] [Google Scholar]
  10. Hawkes C. H., Shephard B. C., Daniel S. E. Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997 May;62(5):436–446. doi: 10.1136/jnnp.62.5.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hughes A. J., Daniel S. E., Kilford L., Lees A. J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181–184. doi: 10.1136/jnnp.55.3.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Joachim C. L., Morris J. H., Selkoe D. J. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases. Ann Neurol. 1988 Jul;24(1):50–56. doi: 10.1002/ana.410240110. [DOI] [PubMed] [Google Scholar]
  13. Koss E., Weiffenbach J. M., Haxby J. V., Friedland R. P. Olfactory detection and identification performance are dissociated in early Alzheimer's disease. Neurology. 1988 Aug;38(8):1228–1232. doi: 10.1212/wnl.38.8.1228. [DOI] [PubMed] [Google Scholar]
  14. Kovács T., Cairns N. J., Lantos P. L. beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease. Neuropathol Appl Neurobiol. 1999 Dec;25(6):481–491. doi: 10.1046/j.1365-2990.1999.00208.x. [DOI] [PubMed] [Google Scholar]
  15. Kuljis R. O., Martín-Vasallo P., Peress N. S. Lewy bodies in tyrosine hydroxylase-synthesizing neurons of the human cerebral cortex. Neurosci Lett. 1989 Nov 20;106(1-2):49–54. doi: 10.1016/0304-3940(89)90200-0. [DOI] [PubMed] [Google Scholar]
  16. Larsson M., Semb H., Winblad B., Amberla K., Wahlund L. O., Bäckman L. Odor identification in normal aging and early Alzheimer's disease: effects of retrieval support. Neuropsychology. 1999 Jan;13(1):47–53. doi: 10.1037//0894-4105.13.1.47. [DOI] [PubMed] [Google Scholar]
  17. Levy L. M., Henkin R. I., Hutter A., Lin C. S., Schellinger D. Mapping brain activation to odorants in patients with smell loss by functional MRI. J Comput Assist Tomogr. 1998 Jan-Feb;22(1):96–103. doi: 10.1097/00004728-199801000-00019. [DOI] [PubMed] [Google Scholar]
  18. McKeith I. G., Galasko D., Kosaka K., Perry E. K., Dickson D. W., Hansen L. A., Salmon D. P., Lowe J., Mirra S. S., Byrne E. J. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996 Nov;47(5):1113–1124. doi: 10.1212/wnl.47.5.1113. [DOI] [PubMed] [Google Scholar]
  19. Mesholam R. I., Moberg P. J., Mahr R. N., Doty R. L. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol. 1998 Jan;55(1):84–90. doi: 10.1001/archneur.55.1.84. [DOI] [PubMed] [Google Scholar]
  20. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991 Apr;41(4):479–486. doi: 10.1212/wnl.41.4.479. [DOI] [PubMed] [Google Scholar]
  21. Mukaetova-Ladinska E. B., Hurt J., Jakes R., Xuereb J., Honer W. G., Wischik C. M. Alpha-synuclein inclusions in Alzheimer and Lewy body diseases. J Neuropathol Exp Neurol. 2000 May;59(5):408–417. doi: 10.1093/jnen/59.5.408. [DOI] [PubMed] [Google Scholar]
  22. Murphy C., Bacon A. W., Bondi M. W., Salmon D. P. Apolipoprotein E status is associated with odor identification deficits in nondemented older persons. Ann N Y Acad Sci. 1998 Nov 30;855:744–750. doi: 10.1111/j.1749-6632.1998.tb10654.x. [DOI] [PubMed] [Google Scholar]
  23. Murphy C., Gilmore M. M., Seery C. S., Salmon D. P., Lasker B. R. Olfactory thresholds are associated with degree of dementia in Alzheimer's disease. Neurobiol Aging. 1990 Jul-Aug;11(4):465–469. doi: 10.1016/0197-4580(90)90014-q. [DOI] [PubMed] [Google Scholar]
  24. Nagy Z., Yilmazer-Hanke D. M., Braak H., Braak E., Schultz C., Hanke J. Assessment of the pathological stages of Alzheimer's disease in thin paraffin sections: a comparative study. Dement Geriatr Cogn Disord. 1998 May-Jun;9(3):140–144. doi: 10.1159/000017038. [DOI] [PubMed] [Google Scholar]
  25. Nordin S., Almkvist O., Berglund B., Wahlund L. O. Olfactory dysfunction for pyridine and dementia progression in Alzheimer disease. Arch Neurol. 1997 Aug;54(8):993–998. doi: 10.1001/archneur.1997.00550200051010. [DOI] [PubMed] [Google Scholar]
  26. Nordin S., Murphy C. Odor memory in normal aging and Alzheimer's disease. Ann N Y Acad Sci. 1998 Nov 30;855:686–693. doi: 10.1111/j.1749-6632.1998.tb10646.x. [DOI] [PubMed] [Google Scholar]
  27. Pearce R. K., Hawkes C. H., Daniel S. E. The anterior olfactory nucleus in Parkinson's disease. Mov Disord. 1995 May;10(3):283–287. doi: 10.1002/mds.870100309. [DOI] [PubMed] [Google Scholar]
  28. Rezek D. L. Olfactory deficits as a neurologic sign in dementia of the Alzheimer type. Arch Neurol. 1987 Oct;44(10):1030–1032. doi: 10.1001/archneur.1987.00520220036012. [DOI] [PubMed] [Google Scholar]
  29. Roth M., Tym E., Mountjoy C. Q., Huppert F. A., Hendrie H., Verma S., Goddard R. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry. 1986 Dec;149:698–709. doi: 10.1192/bjp.149.6.698. [DOI] [PubMed] [Google Scholar]
  30. Schmidt M. L., Martin J. A., Lee V. M., Trojanowski J. Q. Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders. Acta Neuropathol. 1996;91(5):475–481. doi: 10.1007/s004010050454. [DOI] [PubMed] [Google Scholar]
  31. Serby M., Larson P., Kalkstein D. The nature and course of olfactory deficits in Alzheimer's disease. Am J Psychiatry. 1991 Mar;148(3):357–360. doi: 10.1176/ajp.148.3.357. [DOI] [PubMed] [Google Scholar]
  32. Spillantini M. G., Schmidt M. L., Lee V. M., Trojanowski J. Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997 Aug 28;388(6645):839–840. doi: 10.1038/42166. [DOI] [PubMed] [Google Scholar]
  33. Takeda A., Hashimoto M., Mallory M., Sundsumo M., Hansen L., Masliah E. C-terminal alpha-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders. Acta Neuropathol. 2000 Mar;99(3):296–304. doi: 10.1007/pl00007441. [DOI] [PubMed] [Google Scholar]
  34. Yousem D. M., Maldjian J. A., Hummel T., Alsop D. C., Geckle R. J., Kraut M. A., Doty R. L. The effect of age on odor-stimulated functional MR imaging. AJNR Am J Neuroradiol. 1999 Apr;20(4):600–608. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES